| Primary information |
|---|
| CancerPPD ID | 2868 |
| PMID | 22084165 |
| YEAR | 2011 |
| SEQUENCE | KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK |
| LENGTH | 33 |
| NAME | IL-4RaÐlytic hybrid peptide |
| C-ter Modification | Free |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | Mix |
| Non-Natural | None |
| NATURE | Anticancer |
| ACTIVITY | IC50=5.7 µMol/L |
| SOURCE | Interleukin-4 receptor a (IL-4Ra) chain |
| Cancer Type | Breast Cancer |
| ASSAY | WST-1 assay |
| Patent ID | None |
| Tissue | Breast |
| CELL LINE | MDA-MB-231 |
| TEST TIME | 24-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CTTHHHHTTTCSSGGGHHHHHHHHHHHHHHTTC |
| SMILES | N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | >sp_A4XHW0_CLPP_CALS8ATP-dependentClpproteasepr | NA | >tr_E7QUA9_E7QUA9_9EURYPutativeuncharacterizedproteinOS=HaladaptatuspaucihalophilusDX253GN=ZOD2009_1 | NA | NA |
|